Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancerAlan M Keller, Robert G Mennel, Vassilis A Georgoulias, et al.Cancer Chemotherapy and Pharmacology|January 25, 2012
Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancerSandhya Girish, Manish Gupta, Bei Wang, et al.Seminars in Oncology|February 19, 2005
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancerNicholas J Robert, Charles L Vogel, I Craig Henderson, et al.Cancer|June 17, 2014
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancerPeter A Kaufman, Kenneth J Bloom, Howard Burris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapyHoward A Burris, Hope S Rugo, Svetislava J Vukelja, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithmHarold J Burstein, Lyndsay N Harris, P Kelly Marcom, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2006
HER2 testing in breast cancer: NCCN Task Force report and recommendationsRobert W Carlson, Susan J Moench, M Elizabeth H Hammond, et al.Breast (Edinburgh, Scotland)|June 19, 2024
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)Fatima Cardoso, Shani Paluch-Shimon, Eva Schumacher-Wulf, et al.Pageof 4